REG - Iofina PLC - Directorate change

IofinaAnnouncement

12/12/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251212:nRSL2720La&default-theme=true

RNS Number : 2720L  Iofina PLC  12 December 2025

 

 

 

 

 

 

12 December 2025

 

Iofina plc

("Iofina", the "Company" or the "Group")

(AIM: IOF)

 

Directorate Change

 

Iofina plc, specialists in the exploration and production of iodine and
manufacturers of specialty chemical products, is pleased to announce the
proposed appointment of Tim Hughes as a Non-Executive Director, to take effect
from 1 January 2026.

 

Tim has significant experience in general management in the specialty chemical
industry as well as corporate and sustainability matters. Tim was a member of
the Executive Committee of Synthomer plc for 11 years until 2023 as divisional
director for the industrial specialties global business, which included the
company's specialty iodine business, before then becoming President of
Corporate Development, where he was responsible for investor relations,
external affairs and the development of the company's sustainability strategy.

 

Prior to Synthomer, Tim led the Urethane Technologies joint venture business
for Chemtura Corporation and spent 14 years in business leadership and
marketing roles at Courtaulds plc. Tim is based in the UK and holds a BSc in
Chemistry from the University of Manchester and an MBA from Cranfield
University.

 

Concurrent with his appointment, Tim will also be appointed as a member of
Iofina's Audit and Remuneration Committees.

 

Non-Executive Chairman, Lance Baller, commented:

"I'm delighted to welcome Tim to the Board of Iofina. He brings a wealth of
experience from across the global specialty chemical industry. His knowledge
of the iodine sector, combined with his corporate experience, will make him a
valuable asset as the Company continues to expand its iodine production
facilities and unlock new customer markets."

 

Additional Information

Timothy John Hughes, age 61, is currently or has been a Director of the
following companies within the past five years:

 

 Current Directorships                                       Previous Directorships
 Catalyst Science Discovery Centre and Museum Trust Limited  Synthomer (UK) Limited
                                                             (https://find-and-update.company-information.service.gov.uk/company/00872262)
 Chemical Industries Association Limited

 

Enquiries:

 

Iofina plc

Dr. Tom Becker

CEO & President

Tel: +44 (0)20 3006 3135

 

Nomad & Broker:

Canaccord Genuity Limited

Henry Fitzgerald-O'Connor/Harry Rees

Tel: +44 (0)20 7523 8000

 

Financial PR and Media Contact:

Yellow Jersey PR Limited

Charles Goodwin/Shivantha Thambirajah

Tel: +44 (0)7747 788 221/+44 (0)7983 521 488

 

About Iofina:

Iofina plc (AIM: IOF) is a vertically integrated company that specialises in
the production of Iodine and the manufacturing of specialty chemical products.
Iofina is the second largest producer of iodine in North America and operates
the manufacturing entities Iofina Resources and Iofina Chemical.

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

 

Iofina Resources

Iofina Resources develops, builds, owns, and operates iodine extraction plants
using Iofina's WET® IOsorb® technology. Iofina operates eight IOsorb®
plants in Oklahoma and consistently uses technology and innovation to improve
and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high-quality halogen speciality chemicals
derived from raw iodine, as well as non-iodine-based products. Iofina
Chemical celebrated its 40(th) anniversary in 2023 as a preeminent
halogen-based specialty chemicals company.

 

www.iofina.com (http://www.iofina.com/)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAGPGPAPUPAGQG



            Copyright 2019 Regulatory News Service, all rights reserved